Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Exact pricing and protocols are confirmed at a personal consultation
Because: patients eat less but not necessarily better and often without lifestyle restructuring The real risk We may be creating a new phenotype: Weight loss with metabolic fragility (Less overweight, but not necessarily healthier) The question is no longer: Should we prescribe GLP-1 drugs? But: What happens if patients cant stay on themand what are we not fixing underneath? Bottom line GLP-1 drugs are powerful tools
Both contain the same ingredient, semaglutide, but Ozempic is FDA-approved for diabetes, and Wegovy is approved for weight management and cardiovascular protection in people with a history of heart disease
After this initial phase, we will usually transition you to a weekly injection schedule for several weeks, followed by monthly injections for ongoing maintenance
Visit sciencephoto.com for more information and stay connected on Twitter, LinkedIn, Instagram and Vimeo
Analyst 1995;120:8534
US$ 23.39
US$ 22.46
US$ 22.41
US$ 29.41
US$ 21.71
